Ameriprise Financial Inc Co Diagnostics, Inc. Transaction History

Ameriprise Financial Inc

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	SELL	$2.32 - $3.68 $13,223 - $20,976	-5,700 Reduced 32.76%	11,700 $29,000
Q3 2022 Nov 14, 2022	SELL	$2.87 - $7.01 $16,933 - $41,359	-5,900 Reduced 25.32%	17,400 $56,000
Q1 2022 May 16, 2022	BUY	$5.03 - $9.61 $117,199 - $223,913	23,300 New	23,300 $144,000
Q4 2021 Feb 14, 2022	SELL	$8.12 - $10.37 $144,048 - $183,963	-17,740 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$7.48 - $11.38 $28,910 - $43,983	3,865 Added 27.86%	17,740 $172,000
Q2 2021 Aug 16, 2021	BUY	$7.16 - $9.56 $99,345 - $132,645	13,875 New	13,875 $114,000

4.3M

48.2K

53.3K

Ticker CODX
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 33,781,000
Market Cap $35.8M
Description
Co-Diagnostics, Inc., a molecular diagnostics company, develops, manufactures, and sells reagents used for diagnostic tests that function through the detection and/or analysis of nucleic acid molecules in the United States and internationally. It offers polymerase chain reaction (PCR) diagnostic tests for COVID-19, tuberculosis, hepatitis B and ...

Get notified when there are updates to the investment portfolio of Ameriprise Financial Inc, based on Form 13F filings with the SEC.

Stay updated on Ameriprise Financial Inc with notifications on news.